These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25951504)

  • 1. Long-term outcome of prucalopride for chronic constipation: a single-centre study.
    Dhruva Rao PK; Lewis M; Peiris SP; Shah PR; Haray PN
    Colorectal Dis; 2015 Dec; 17(12):1079-84. PubMed ID: 25951504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
    Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
    Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M; Kerstens R; Rykx A; Vandeplassche L
    N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief.
    Pennant M; Orlando R; Barton P; Bayliss S; Routh K; Meads C
    Health Technol Assess; 2011 May; 15 Suppl 1():43-50. PubMed ID: 21609652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM; Vandeplassche L; Kerstens R; Ausma J
    Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
    Cinca R; Chera D; Gruss HJ; Halphen M
    Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
    Camilleri M; Van Outryve MJ; Beyens G; Kerstens R; Robinson P; Vandeplassche L
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1113-23. PubMed ID: 21039673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
    Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R
    Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between prucalopride efficacy and constipation type.
    Jadav AM; McMullin CM; Smith J; Chapple K; Brown SR
    Tech Coloproctol; 2013 Oct; 17(5):555-9. PubMed ID: 23703575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prucalopride.
    Frampton JE
    Drugs; 2009; 69(17):2463-76. PubMed ID: 19911858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety/Efficacy of Prucalopride in Korean Patients with Chronic Constipation: Post-marketing Surveillance.
    Yeon SE; Kim SY; Chung WC; Jeon SW; Park SJ; Choi CH; Choi MG
    Korean J Gastroenterol; 2021 Oct; 78(4):219-226. PubMed ID: 34697276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some practical questions on chronic stipsis treatment with prucalopride].
    Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prucalopride succinate for the treatment of constipation: an update.
    Bassotti G; Gambaccini D; Bellini M
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial.
    Coremans G; Kerstens R; De Pauw M; Stevens M
    Digestion; 2003; 67(1-2):82-9. PubMed ID: 12743445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation.
    Sloots CE; Rykx A; Cools M; Kerstens R; De Pauw M
    Dig Dis Sci; 2010 Oct; 55(10):2912-21. PubMed ID: 20428949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What role for prucalopride in constipation?
    Drug Ther Bull; 2011 Aug; 49(8):93-6. PubMed ID: 21831905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prucalopride: a new drug for the treatment of chronic constipation.
    Tack J
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):337-43. PubMed ID: 19673621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride.
    Piessevaux H; Corazziari E; Rey E; Simren M; Wiechowska-Kozlowska A; Kerstens R; Cools M; Barrett K; Levine A
    Neurogastroenterol Motil; 2015 Jun; 27(6):805-15. PubMed ID: 25808103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prucalopride on symptoms of chronic constipation.
    Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
    Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Prucalopride for Chronic Idiopathic Constipation: An Analysis of Participants With Moderate to Very Severe Abdominal Bloating.
    Staller K; Hinson J; Kerstens R; Spalding W; Lembo A
    Am J Gastroenterol; 2022 Jan; 117(1):184-188. PubMed ID: 34585675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.